Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Wells G, Coyle D, Cameron C, et al. Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Apr 9.
Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation [Internet].
Show details- AF
atrial fibrillation
- CIHR
Canadian Institutes of Health Research
- CI
confidence interval
- CrI
credibility interval
- CRNM
clinically relevant non-major
- CV
cardiovascular
- DARE
Database of Abstracts of Reviews of Effects
- DSEN
Drug Safety and Effectiveness Network
- FDA
Food and Drug Administration
- FXa
factor Xa
- GI
gastrointestinal
- GRADE
Grading of Recommendations Assessment, Development and Evaluation
- GLMM
generalized linear mixed models
- ICH
intracerebral hemorrhage
- INR
international normalized ratio
- ISTH
International Society on Thrombosis and Haemostasis
- ITT
intention to treat
- MCMC
Markov chain Monte Carlo
- MI
myocardial infarction
- MTC
mixed treatment comparison
- λ
maximum willingness to pay
- NICE
National Institute for Health and Clinical Excellence
- NOAC
new oral anticoagulant
- NRS
non-randomized study
- NSAID
nonsteroidal antiinflammatory drug
- OR
odds ratio
- PE
pulmonary embolism
- PICO
patient/population, intervention, comparator and outcome
- QALY
quality-adjusted life-year
- RCT
randomized controlled trial
- ROB
risk of bias
- SE
systemic embolism
- SIGN
Scottish Intercollegiate Guidelines Network
- TIA
transient ischemic attack
- TTR
time in therapeutic range
- VKA
vitamin K antagonist
- ABBREVIATIONS - Safety, Effectiveness, and Cost-Effectiveness of New Oral Antico...ABBREVIATIONS - Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation
Your browsing activity is empty.
Activity recording is turned off.
See more...